Vitamin D supplementation in critically ill patients: a meta-analysis
Frontiers in Nutrition · 30.04.2025 · 12
DOI: 10.3389/fnut.2025.1505616 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 30.04.2025. Verfasst von Wen-He Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Second People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vitamin D is commonly used in clinical practice, while its clinical significance in critically ill patients remains controversial. Therefore, we aimed to perform a systemic review and meta-analysis to investigate the effect of vitamin D on this patient population.
Methods
We searched for randomized controlled trials (RCTs) in PubMed, Embase, and the Cochrane Library databases from inception until August 15, 2024. Studies evaluating critically ill adult patients who received vitamin D compared to controls were included. The primary outcome was short-term mortality. We used the Cochrane risk of bias tool and GRADE system to evaluate the study quality and evidence. Secondary outcomes were changes in serum 25-hydroxyvitamin D levels, mechanical ventilation (MV) duration, and length of stay (LOS) in the ICU or hospital. We also conducted meta-regression, subgroup analyses, and trial sequential analysis (TSA) to explore the potential heterogeneity among the included trials.
Results
Nineteen RCTs with 2,754 patients were eligible. Overall, vitamin D significantly increased serum 25-hydroxyvitamin D levels and significantly reduced the short-term mortality (risk ratio [RR] = 0.83; 95%CI, 0.70–0.98; p = 0.03, I 2 = 13%), duration of MV (MD = −2.96 days; 95% CI, −5.39 to −0.52; I 2 = 77%; p = 0.02) and ICU LOS (MD = −2.66 days; 95% CI, −4.04 to −1.29, I 2 = 70%; p = 0.0001) but not hospital LOS (MD = −0.48 days; 95% CI, −2.37 to 1.40; I 2 = 31%; p = 0.61). The meta-regression analysis revealed that the proportion of MV (MV%) accounted for the source of heterogeneity, and the subgroup analyses based on MV% suggested that the MV group was more likely to benefit from vitamin D applications than the partly MV group in all the predefined outcomes (all p values<0.05). TSA for short-term mortality suggested that more data is required to confirm our main conclusion.
Conclusion
Vitamin D supplementation increased serum 25-hydroxyvitamin D levels and significantly benefited critically ill patients, especially those with MV. Systematic review registration https://inplasy.com/inplasy-2022-10-0074/ , INPLASY2022100074.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The Second People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Fuzhou, China.
- Department of Critical Care Medicine, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zitieren
APA
Zheng, W. H., Shi, J. H., Yu, D. X., & Huang, H. B. (2025). Vitamin D supplementation in critically ill patients: a meta-analysis. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1505616
Vancouver
Zheng WH, Shi JH, Yu DX, Huang HB. Vitamin D supplementation in critically ill patients: a meta-analysis. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1505616
BibTeX
@article{Zheng2025,
author = {Zheng, Wen-He and Shi, Jia-Heng and Yu, Da-Xing and Huang, Hui-Bin},
title = {Vitamin D supplementation in critically ill patients: a meta-analysis},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1505616}
}
EUVIMED